Association Between Serum 25-hydroxyvitamin D3 Level and Cognitive Impairment in Older Chronic Kidney Disease Patients

Overview

Journal Sci Rep

Specialty Science

Date 2024 May 29

PMID 38811765

Authors

Jialing Zhang

Aihua Zhang

Affiliations

Soon will be listed here.

Abstract

This study aims to examine whether hypovitaminosis D was associated with cognitive impairment among chronic kidney patients with different level of albuminuria. This population-based cross-sectional study was conducted on elderly (over 60 years old) with urine albumin to creatinine ratio (UACR) ≥ 30 mg/g from 2011 to 2014 in the US National Health and Nutrition Examination Survey (NHANES). Cognitive function was assessed by the Consortium to Establish a Registry for Alzheimer's Disease Word List Learning (CERAD). Subjects were divided into 2 groups according to the absence or presence of cognitive impairment and a propensity score matching (PSM) was further conducted. The association was assessed with Spearman correlation and logistic regression analysis. The positive association of 25-hydroxyvitamin D3 (25(OH)D3) and cognitive score was presented. PSM analysis revealed that a higher level of 25(OH)D3 correlated to a better cognitive function in CKD patients with albuminuria, especially in patients with 30 mg/g ≤ UACR < 300 mg/g. This study indicated that a low 25(OH)D3 level was associated with poor cognitive performance, especially in patients with microalbuminuria. Thus, early diagnosis of vitamin D insufficiency and an effective intervention might be a useful therapeutic strategy to prevent cognitive decline in patients with the progression of renal dysfunction.

References

Schlogl M, Holick M . Vitamin D and neurocognitive function. Clin Interv Aging. 2014; 9:559-68. PMC: 3979692. DOI: 10.2147/CIA.S51785. View

Cetinkalp S, Delen Y, Karadeniz M, Yuce G, Yilmaz C . The effect of 1alpha,25(OH)2D3 vitamin over oxidative stress and biochemical parameters in rats where Type 1 diabetes is formed by streptozotocin. J Diabetes Complications. 2008; 23(6):401-8. DOI: 10.1016/j.jdiacomp.2008.09.005. View

Fabricio D, Chagas M, Diniz B . Frailty and cognitive decline. Transl Res. 2020; 221:58-64. DOI: 10.1016/j.trsl.2020.01.002. View

Petersen M, Bech S, Christiansen D, Schmedes A, Halling J . The role of vitamin D levels and vitamin D receptor polymorphism on Parkinson's disease in the Faroe Islands. Neurosci Lett. 2014; 561:74-9. DOI: 10.1016/j.neulet.2013.12.053. View

Xie Y, Bowe B, Mokdad A, Xian H, Yan Y, Li T . Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018; 94(3):567-581. DOI: 10.1016/j.kint.2018.04.011. View

Watanabe K, Watanabe T, Nakayama M . Cerebro-renal interactions: impact of uremic toxins on cognitive function. Neurotoxicology. 2014; 44:184-93. DOI: 10.1016/j.neuro.2014.06.014. View

Al-Amin M, Bradford D, Sullivan R, Kurniawan N, Moon Y, Han S . Vitamin D deficiency is associated with reduced hippocampal volume and disrupted structural connectivity in patients with mild cognitive impairment. Hum Brain Mapp. 2018; 40(2):394-406. PMC: 6865549. DOI: 10.1002/hbm.24380. View

Levey A, de Jong P, Coresh J, El Nahas M, Astor B, Matsushita K . The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2010; 80(1):17-28. DOI: 10.1038/ki.2010.483. View

Stevens P, Levin A . Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013; 158(11):825-30. DOI: 10.7326/0003-4819-158-11-201306040-00007. View

10.

Fullard M, Duda J . A Review of the Relationship Between Vitamin D and Parkinson Disease Symptoms. Front Neurol. 2020; 11:454. PMC: 7267215. DOI: 10.3389/fneur.2020.00454. View

11.

McCann J, Ames B . Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?. FASEB J. 2007; 22(4):982-1001. DOI: 10.1096/fj.07-9326rev. View

12.

Mizwicki M, Liu G, Fiala M, Magpantay L, Sayre J, Siani A . 1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients. J Alzheimers Dis. 2012; 34(1):155-70. PMC: 4040018. DOI: 10.3233/JAD-121735. View

13.

Liu G, Pi H, Hao L, Li D, Wu Y, Dong J . Vitamin D Status Is an Independent Risk Factor for Global Cognitive Impairment in Peritoneal Dialysis Patients. PLoS One. 2015; 10(12):e0143782. PMC: 4668056. DOI: 10.1371/journal.pone.0143782. View

14.

Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K . 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 2009; 17(3):703-17. DOI: 10.3233/JAD-2009-1080. View

15.

Morris J, HEYMAN A, Mohs R, Hughes J, van Belle G, Fillenbaum G . The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989; 39(9):1159-65. DOI: 10.1212/wnl.39.9.1159. View

16.

Hooper S, Gerson A, Butler R, Gipson D, Mendley S, Lande M . Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease. Clin J Am Soc Nephrol. 2011; 6(8):1824-30. PMC: 3156421. DOI: 10.2215/CJN.09751110. View

17.

Murray A, Phuong Thao L, Ryan J, Wolfe R, Wetmore J, Woods R . CKD Biomarkers, Cognitive Impairment, and Incident Dementia in an Older Healthy Cohort. Kidney360. 2022; 3(3):435-445. PMC: 9034805. DOI: 10.34067/KID.0005672021. View

18.

Giannos P, Prokopidis K, Church D, Kirk B, Morgan P, Ni Lochlainn M . Associations of Bioavailable Serum Testosterone With Cognitive Function in Older Men: Results From the National Health and Nutrition Examination Survey. J Gerontol A Biol Sci Med Sci. 2022; 78(1):151-157. PMC: 9879757. DOI: 10.1093/gerona/glac162. View

19.

Henderson V . Progesterone and human cognition. Climacteric. 2018; 21(4):333-340. PMC: 6309195. DOI: 10.1080/13697137.2018.1476484. View

20.

Annweiler C, Dursun E, Feron F, Gezen-Ak D, Kalueff A, Littlejohns T . 'Vitamin D and cognition in older adults': updated international recommendations. J Intern Med. 2014; 277(1):45-57. DOI: 10.1111/joim.12279. View